FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation

Author： Brinkmann V.V.   Pinschewer D.D.   Chiba K.K.   Feng L.L.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.2, 2000-02, pp. : 49-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FTY 720: effective immunosuppression in transplantation

By  

Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis

By Baumruker Thomas   Billich Andreas   Brinkmann Volker  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 283-289

Informa Healthcare

Access to resources Recommend Favorite

Is Omapatrilat a Novel Therapy of the Past Rather Than the Future?

By Cheng T.O.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 630-631

Adis International

Access to resources Recommend Favorite

FTY720: A Most Promising Immunosuppressant Modulating Immune Cell Functions

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-08 ,pp. : 845-850

Bentham Science Publishers

Access to resources Recommend Favorite

Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage

By  

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 861-866

Bentham Science Publishers

Access to resources Recommend Favorite